|
Volumn 11, Issue 1, 1985, Pages 5-22
|
The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984
|
Author keywords
Chemotherapy; Combined modality therapy; Hodgkin's disease; Radiotherapy
|
Indexed keywords
BLEOMYCIN;
CHLORMETHINE;
DACARBAZINE;
DOXORUBICIN;
METHOTREXATE;
PREDNISONE;
PROCARBAZINE;
VINBLASTINE;
VINCRISTINE;
BLOOD AND HEMOPOIETIC SYSTEM;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG THERAPY;
HODGKIN DISEASE;
HUMAN;
PRIORITY JOURNAL;
RADIOTHERAPY;
RANDOMIZED CONTROLLED TRIAL;
SHORT SURVEY;
THERAPY;
ADOLESCENT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHILD;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
COMPARATIVE STUDY;
FEMALE;
HODGKIN DISEASE;
HUMAN;
INFERTILITY;
LEUKEMIA, MYELOCYTIC, ACUTE;
LEUKEMIA, RADIATION-INDUCED;
LYMPH NODES;
LYMPHOMA;
MALE;
MECHLORETHAMINE;
NEOPLASM STAGING;
PREDNISONE;
PROCARBAZINE;
PROGNOSIS;
RADIATION INJURIES;
RANDOM ALLOCATION;
SEPTICEMIA;
SUPPORT, U.S. GOV'T, P.H.S.;
VINCRISTINE;
|
EID: 0022005980
PISSN: 03603016
EISSN: None
Source Type: Journal
DOI: 10.1016/0360-3016(85)90357-8 Document Type: Article |
Times cited : (184)
|
References (45)
|